文献速递关节外科创伤骨科

Marlex网重建伸膝装置:术后石膏固定是否必要?

Extensor Mechanism Reconstruction Using Marlex Mesh: Is Postoperative Casting Mandatory?
PubMed 文献 · J Arthroplasty · 2020-06-18

回顾性分析33膝(30例)全膝关节置换术后伸膝装置断裂行Marlex网重建,比较长腿石膏与膝支具两种术后制动方式。平均随访25个月,58%重建功能良好,排除感染取出后73%在位;6年生存率69%,制动方式无显著影响(石膏67% vs 支具71%,P=.74)。伸膝滞后从术前平均43°改善至术后平均9°。

要点

  • Marlex网重建伸膝装置在非设计机构也可获得可接受的临床结果
  • 术后制动方式(长腿石膏 vs 膝支具)不影响6年生存率(67% vs 71%,P=.74)

核心结论

  • Marlex网重建伸膝装置是持久可靠的治疗,在设计机构之外也可获得可接受的临床结果。
  • 只要术后制动持续时间充足且依从性良好,长腿石膏或膝支具均可获得相似结果。

研究设计与样本

  • 回顾性综述了2012年至2019年间连续行伸膝装置重建的病例,排除初次修复和异体骨重建,纳入33膝(30例)行Marlex网重建。
  • 术后19/33膝(58%)使用膝支具,14/33膝(42%)使用长腿石膏。
  • 采用Kaplan-Meier分析确定无网失败的全因生存率。

主要发现

  • 平均随访25个月时,19/33(58%)伸膝装置重建功能良好;排除取出感染的病例(5例复发感染和2例新发感染)后,19/26(73%)重建在位。
  • 6年生存率为69%,制动方式无显著影响(石膏组67% vs 膝支具组71%,P=.74)。
  • 伸膝滞后与制动方式无关,从术前平均43°改善至术后平均9°。
  • 在成功的病例中,加州大学洛杉矶分校活动评分和膝关节损伤与骨关节炎结果评分-关节置换评分的改善超过最小临床重要差异(分别为2.2-3.3和52.5-64.0)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Extensor mechanism (EM) disruption after total knee arthroplasty is a catastrophic complication. Reconstruction using monofilament polypropylene mesh (Marlex Mesh; CR Bard, Franklin Lakes, NJ) has emerged as the preferred treatment, but reports are limited to the designing institution. This study describes a nondesigner experience and compares 2 postoperative immobilization strategies: long leg cast vs knee immobilizer. METHODS: A retrospective review of consecutive EM reconstructions between 2012 and 2019 was performed. Primary repairs and allograft reconstructions were excluded, leaving 33 knees (30 patients) who underwent Marlex reconstruction. Mean time from disruption to reconstruction was 14 months, and 14 of 33 (42%) had previous repair or reconstruction attempts. The mean age was 69 years, and mean body mass index was 35 kg/m2. Postoperatively, extension was maintained using a knee immobilizer in 19 of 33 (58%) patients, whereas 14 of 33 (42%) patients were long leg casted. Kaplan-Meier analysis determined all-cause survivorship free of mesh failure. RESULTS: At mean 25-month follow-up, 19 of 33 (58%) EM reconstructions were functioning. Excluding explanted infections (5 recurrent and 2 new), 19 of 26 (73%) EM reconstructions were in situ. Six-year survivorship was 69% and not influenced by immobilization type (cast: 67%, immobilizer: 71%; P = .74). Extensor lag was not associated with immobilization type, improving from a mean preoperative lag of 43° to a mean postoperative lag of 9°. Among successes, University of California at Los Angeles activity and Knee Injury and Osteoarthritis Outcome Score - Joint Replacement score improvements exceeded minimal clinically important difference (2.2-3.3 and 52.5-64.0, respectively). CONCLUSION: Marlex mesh EM reconstruction is a durable and reliable treatment with acceptable clinical results achievable outside the designer institution. Provided sufficient duration and compliance with postoperative immobilization, similar outcomes can be obtained with either a cast immobilizer or a knee immobilizer.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Buller LT, Warth LC, Deckard ER, et al. Extensor Mechanism Reconstruction Using Marlex Mesh: Is Postoperative Casting Mandatory? J Arthroplasty. 2020. PMID: 32646680. doi:10.1016/j.arth.2020.06.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。